LONDON BROKER RATINGS: Morgan Stanley cuts Mondi; BofA cuts Ashtead
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More
| Price | 524.00p on 23-01-2026 at 18:40:05 |
|---|---|
| Change | 8.00p 1.55% |
| Buy | 526.00p |
| Sell | 524.00p |
| Last Trade: | Sell 400.00 at 525.00p |
| Day's Volume: | 1,286,367 |
| Last Close: | 524.00p |
| Open: | 503.00p |
| ISIN: | GB00B45C9X44 |
| Day's Range | 503.00p - 527.00p |
| 52wk Range: | 297.50p - 614.00p |
| Market Capitalisation: | £1.41b |
| VWAP: | 519.58804p |
| Shares in Issue: | 268.97m |
Chemring (CHG) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 400 | 525.00p | Automatic Execution |
16:29:41 - 23-Jan-26 |
| Sell* | 692 | 525.00p | Automatic Execution |
16:29:26 - 23-Jan-26 |
| Buy* | 316 | 525.00p | Automatic Execution |
16:29:26 - 23-Jan-26 |
| Buy* | 530 | 525.00p | Automatic Execution |
16:29:26 - 23-Jan-26 |
| Buy* | 12,229 | 525.00p | Automatic Execution |
16:29:26 - 23-Jan-26 |
| Sell* | 400 | 525.00p | Automatic Execution |
16:29:26 - 23-Jan-26 |
| Sell* | 340 | 525.00p | Automatic Execution |
16:29:26 - 23-Jan-26 |
| Sell* | 600 | 525.00p | Automatic Execution |
16:29:26 - 23-Jan-26 |
| Buy* | 761 | 525.5645p | Ordinary |
16:29:07 - 23-Jan-26 |
| Unknown* | 0 | 526.00p | SI Trade |
16:28:55 - 23-Jan-26 |
Chemring (CHG) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 23rd Jan 2026 4:41 pm | RNS | Director/PDMR Shareholding |
| 12th Jan 2026 1:35 pm | RNS | Notice of AGM |
| 2nd Jan 2026 10:29 am | RNS | Total Voting Rights |
| 19th Dec 2025 11:53 am | RNS | Holding(s) in Company |
| 19th Dec 2025 11:53 am | RNS | Holding(s) in Company |
| 18th Dec 2025 7:00 am | RNS | Block listing Interim Review |
| 16th Dec 2025 7:00 am | RNS | Director/PDMR Shareholding |
| 16th Dec 2025 7:00 am | RNS | Director/PDMR Shareholding |
| 16th Dec 2025 7:00 am | RNS | Director/PDMR Shareholding |
| 16th Dec 2025 7:00 am | RNS | Director/PDMR Shareholding |